188 related articles for article (PubMed ID: 18552820)
1. Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system.
Su MC; Yuan RH; Lin CY; Jeng YM
Mod Pathol; 2008 Nov; 21(11):1379-86. PubMed ID: 18552820
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2.
Panarelli NC; Yantiss RK; Yeh MM; Liu Y; Chen YT
Am J Clin Pathol; 2012 Aug; 138(2):211-22. PubMed ID: 22904132
[TBL] [Abstract][Full Text] [Related]
3. Claudin-18 as a Marker for Identifying the Stomach and Pancreatobiliary Tract as the Primary Sites of Metastatic Adenocarcinoma.
Li WT; Jeng YM; Yang CY
Am J Surg Pathol; 2020 Dec; 44(12):1643-1648. PubMed ID: 32925194
[TBL] [Abstract][Full Text] [Related]
4. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
Bayrak R; Haltas H; Yenidunya S
Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
[TBL] [Abstract][Full Text] [Related]
5. Cadherin 17 is a novel diagnostic marker for adenocarcinomas of the digestive system.
Ordóñez NG
Adv Anat Pathol; 2014 Mar; 21(2):131-7. PubMed ID: 24508695
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers.
Rao Q; Williamson SR; Lopez-Beltran A; Montironi R; Huang W; Eble JN; Grignon DJ; Koch MO; Idrees MT; Emerson RE; Zhou XJ; Zhang S; Baldridge LA; Cheng L
Mod Pathol; 2013 May; 26(5):725-32. PubMed ID: 23348900
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid.
Matsuura K; Kawanishi J; Fujii S; Imamura M; Hirano S; Takeichi M; Niitsu Y
Br J Cancer; 1992 Dec; 66(6):1122-30. PubMed ID: 1333788
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical studies on the localization of cancer associated antigens DU-PAN-2 and CA19-9 in carcinomas of the digestive tract.
Ohshio G; Ogawa K; Kudo H; Yamabe H; Nakashima Y; Kim YC; Endo K; Watanabe Y; Manabe T; Tobe T
J Gastroenterol Hepatol; 1990; 5(1):25-31. PubMed ID: 2103381
[TBL] [Abstract][Full Text] [Related]
9. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study.
Villari D; Caruso R; Grosso M; Vitarelli E; Righi M; Barresi G
Pathology; 2002 Oct; 34(5):423-6. PubMed ID: 12408340
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.
Wang HL; Lu DW; Yerian LM; Alsikafi N; Steinberg G; Hart J; Yang XJ
Am J Surg Pathol; 2001 Nov; 25(11):1380-7. PubMed ID: 11684954
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of E-cadherin expression in human colorectal tumours.
Van Aken J; Cuvelier CA; De Wever N; Roels J; Gao Y; Mareel MM
Pathol Res Pract; 1993 Nov; 189(9):975-8. PubMed ID: 8302730
[TBL] [Abstract][Full Text] [Related]
12. T-complex-associated-testis-expressed 3 (TCTE3) is a novel marker for pancreatobiliary carcinomas.
Zhao CL; Hui Y; Wang LJ; Lombardo K; Yang D; Mangray S; Yakirevich E; Amin A; Huang CK; Lu S
Hum Pathol; 2017 Dec; 70():62-69. PubMed ID: 29079176
[TBL] [Abstract][Full Text] [Related]
13. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
[TBL] [Abstract][Full Text] [Related]
14. CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2.
Altree-Tacha D; Tyrrell J; Haas T
Arch Pathol Lab Med; 2017 Jan; 141(1):144-150. PubMed ID: 28029907
[TBL] [Abstract][Full Text] [Related]
15. [E-cadherin molecular expresion in the diffuse and intestinal types of gastric adenocarcinoma. A report from Lima, Peru].
Arévalo F; Monge E; Morales D
Rev Esp Enferm Dig; 2007 Jun; 99(6):325-9. PubMed ID: 17883295
[TBL] [Abstract][Full Text] [Related]
16. Use of E-cadherin and CD44 aids in the differentiation between reactive mesothelial cells and carcinoma cells in pelvic washings.
Chhieng DC; Yee H; Cangiarella JF; Symmans WF; Cohen JM
Cancer; 2000 Oct; 90(5):299-306. PubMed ID: 11038427
[TBL] [Abstract][Full Text] [Related]
17. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W
J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444
[TBL] [Abstract][Full Text] [Related]
18. Expression of E- and P-cadherin in gastric carcinomas.
Shimoyama Y; Hirohashi S
Cancer Res; 1991 Apr; 51(8):2185-92. PubMed ID: 2009537
[TBL] [Abstract][Full Text] [Related]
19. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas.
Kaimaktchiev V; Terracciano L; Tornillo L; Spichtin H; Stoios D; Bundi M; Korcheva V; Mirlacher M; Loda M; Sauter G; Corless CL
Mod Pathol; 2004 Nov; 17(11):1392-9. PubMed ID: 15205684
[TBL] [Abstract][Full Text] [Related]
20. N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas.
Mosnier JF; Kandel C; Cazals-Hatem D; Bou-Hanna C; Gournay J; Jarry A; Laboisse CL
Mod Pathol; 2009 Feb; 22(2):182-90. PubMed ID: 18622386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
